

Year: 2016
Pharmaceutical Outsourcing Magazine Interview Nov-Dec 2016
- Updated Offerings
- November 29, 2016
- Michael Millhollen
For their November/December 2016 issue, Pharmaceutical Outsourcing Magazine interviewed Chris Bohl, PhD, Global Technical Support Manager for SEKISUI XenoTech’s Products Division, on...
SEKISUI XenoTech Standardizes Lysosomal Test Systems for Biopharmaceutical Development
- Test Systems & Methods
- October 5, 2016
- Dr. Chris Bohl
Before releasing these test systems, there was not a high quality, specific, relevant, easy and ready to use, in vitro test system to...
SEKISUI XenoTech Joins Fight Against Liver Disease
- Disease-Specific Resources
- September 16, 2016
- Dr. Maciej Czerwinski, Michael Millhollen
SEKISUI XenoTech is committed to furthering the knowledge surrounding hepatic diseases, such as nonalcoholic fatty liver disease (NAFLD) and nonalcoholic...
SEKISUI XenoTech Featured on Labiotech.EU
- Enzyme Inhibition
- July 5, 2016
- Michael Millhollen
Understand which transporters are involved in a drug’s absorption, distribution & excretion Originally posted on Labiotech.EU How can you build the...
XenoTech Scientists Publish Paper, Present Research Evaluating Ketoconazole and its Alternative Clinical CYP3A4-5 Inhibitors as Inhibitors of Drug Transporters
- Enzyme Inhibition
- April 25, 2016
- Michael Millhollen
SEKISUI XenoTech scientists published a paper in Drug Metabolism and Disposition evaluating Ketoconazole and its alternative clinical CYP3A4-5 inhibitors as inhibitors of drug...
SEKISUI XenoTech Fulfills Largest Order To Date
- Accomplishments
- February 1, 2016
- Michael Millhollen
Sekisui XenoTech recently fulfilled its largest order of human liver subcellular fractions to date. A large pharmaceutical customer ordered over...
Subscribe to our Newsletter
Stay up to date with our news, events and research

Do you have a question or a request for upcoming blog content?
We love to get your feedback
